Mr Lewis Baird United Kingdom

Datatrial is an eClinical solutions company, providing comprehensive data management, bio-statistical and consulting services. We have our own proprietary software, nowEDC™ which has been deployed globally in Phase I to Phase III trials.  Our ethos is to collaborate with our customers to find and offer solutions that will assist in the achievement of clinical objectives.

 

Company type
Mr Lewis Baird
Datatrial Limited
LinkedIn logo Business Development Manager 

Mr Mike Baker

Ockham provides high-quality, global clinical research and strategic development services to pharmaceutical and biotechnology companies, assisting them in the achievement of their strategic planning, technology transfer, licensing, regulatory planning and submissions, pre-clinical development, and manufacturing goals. 

Ockham also provides fully integrated clinical trials support in the areas of Clinical Operations, Data Management and Biostatistics, as well as Regulatory dossier compilations. In addition, it offers functional and specialty resourcing services to pharmaceutical, biotech and medical device companies that require Clinical Operations, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), or Good Manufacturing Practice (GMP) auditing, Data Management, Statistical Programming, Biostatistics, and Medical Writing solutions.

Website:
www.ockham.com
Company type
Ockham Oncology
Vice President 

Mr Stephen Barr United Kingdom

Almac provides a comprehensive range of integrated services from research through to commercialisation.  Almac is a financially stable, privately owned organisation with over 3,300 employees located within the US and UK. Over 95% of work is repeat business, testament itself to the quality, innovation, efficiency and the high level of customer satisfaction provided.   

Services Offered
Almac’s integrated solutions extend from research to commercialisation and include:

Biomarker Discovery & Development:
·         Companion Diagnostic Development
·         Genomic Services
·         Bioinformatics Consultancy
·         Proprietary Discovery Arrays 

API Services & Chemical Development:
·         API Development & Manufacture
·         Peptide & Protein Technology
·         Accelerated First in Man Solution
·         Solid State Services
·         Isotope Chemistry
·         Biocatalysis
     
Pharmaceutical Development: 
·         Preformulation & Early Stage Development
·         Scale Up and Late Stage Development
·         Clinical Trial Manufacture
·         Contained Development & Manufacture

Analytical Services:
·         Physical & Chemical Characterisation
·         Method Development & Validation
·         API & Drug Product Testing
·         Stability Testing

Clinical Trial Supply:
·         Comparator Blinding
·         Packaging & Labelling
·         QP Release
·         Global Distribution & Supply Chain Management

Clinical Technologies:
·         IVR / Web
·         ePRO
·         Statistical Services

Commercial Services
·         Manufacturing & Packaging
·         Product Launch & Distribution

Come and see us at booth #64

Company type
Almac Group
Managing Director 

Dr Alessandra Basso United Kingdom


A leader in ion exchange and resin technology—and one of the world’s largest
developers and manufacturers of high-quality APIs, blood purification polymers, enzyme carriers, chromatographic resins and ion exchange products—Purolite is introducing the new product line based on agarose in our cGMP, FDA regulated facility.
With three strategically located production plants, five global R&D centers—including a research center of excellence in the UK—and a sales force made up of industry experts, Purolite is your solutions company for quality products, stability of manufacturing and knowledgeable service.

Developed and manufactured by Purolite, innovative agarose-based biochromatography resins will expand the LifeTech family of products to cover SEC, HIC, IEX and affinity bio-purification media for the fast-growing biosimilars market.
LifeTech bio-based resins will support customer needs—from drug development with pre-packed columns, to bulk media for industrial production of biosimilars.

Website:
www.purolite.com
Company type
Purolite
LifeTech Manager 

Mr Steve Bates United Kingdom

Established in 1989, the BIA (BioIndustry Association) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies with whom such enterprise trades. 

With over 300 members, the BIA supports a wide range of sectors, majoring on the human health benefits of the technology and represents the interests of these innovative companies to a broad section of stakeholders from patient groups to politicians, advancing its members interests both within the UK and internationally to create a healthy UK bioscience sector which benefits society.

Company type
BioIndustry Association (BIA)
CEO 

Ms Lin Bateson United Kingdom

BioPartner is your UK point of contact at Bio-Europe 2013 based at stand #68.

BioPartner is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. Through the BioPartnership Programme, BioPartner assists companies to attend major international biopharma conferences by providing access to government grants and heavily discounted entry fees.

Company type
BioPartner UK
LinkedIn logo Executive Director 

Ms Della Bateson-Chaffe United Kingdom

BioPartner is your UK point of contact at Bio-Europe 2013 based at stand #68.

BioPartner is an independent, accredited trade organisation, promoting international partnering for trade, investment and collaborations with UK Life Science companies. Through the BioPartnership Programme, BioPartner assists companies to attend major international biopharma conferences by providing access to government grants and heavily discounted entry fees.

Company type
BioPartner UK
LinkedIn logo Administrator 

Dr Grahaem Brown United Kingdom

About Competitive Drug Development International Ltd.

 

CDDI is an international biotechnology and pharmaceutical consulting company, led by senior people who together have developed more than 20 products globally from discovery to market. CDDI can give support with a broad range of drug development activities across the three key disciplines of Clinical, Non-clinical and CMC.

 

Services include Virtual Asset Development (VAD), where CDDI provides a fully integrated development team directed by strong project leadership, Evidence Based Protocol Feasibility (ebf) for data-driven and rapid patient recruitment, and CMC services from API and formulation development of NCEs and NBEs, through to CMO management of GMP manufacturing.

 

Our working method is hands-on, not just consulting, which means, we don’t just advise you, but actively implement the strategies and plans that we formulate with you. For more information please visit www.cddi.co.

Website:
www.cddi.co
Company type
Dr Grahaem Brown
CDDI
Managing Partner